Showing results (271-280 of 363) with videos related to

Sort By:
Pageof 37
British Journal of Pharmacology|November 1, 1994
Vasoconstrictor and vasodilator responses to various agonists in the rat perfused mesenteric arterial bed: selective inhibition by PPADS of contractions mediated via P2x-purinoceptorsU Windscheif, V Ralevic, H G Bäumert, et al.
Arzneimittel-Forschung|January 1, 1979
Pharmacokinetics of a fixed combination with propranolol, hydrochlorothiazide and triamtereneK Felder, H E Geissler, S Hiemstra, et al.
British Journal of Pharmacology|October 1, 1996
Protective action of hydroxyethyl rutosides on singlet oxygen challenged cardiomyocytesH G Olbrich, P Grabisch, A Grossmann, et al.
Biopharmaceutics & Drug Disposition|January 1, 1983
Influence of inflammatory disease on the clinical pharmacokinetics of atenolol and metoprololW Kirch, H Spahn, E E Ohnhaus, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 7, 1998
Intracellular pH regulation in bovine aortic endothelial cells: evidence of both Na+/H+ exchange and Na+-dependent Cl-/HCO3- exchangeS Faber, H J Lang, F J Hock, et al.
Clinical Pharmacology and Therapeutics|December 1, 1987
Digoxin concentrations in serum and cantharides blister fluid: correlations with cardiac responseM Schäfer-Korting, G G Belz, J Brauer, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1991
Antagonist binding profiles of five cloned human muscarinic receptor subtypesF Dörje, J Wess, G Lambrecht, et al.
Chirality|January 1, 1993
Rats with portacaval shunt as a potential experimental pharmacokinetic model for liver cirrhosis: application to carvedilol stereopharmacokineticsE Stahl, U Baumgartner, D Henke, et al.
Arzneimittel-Forschung|September 1, 1993
Pharmacokinetics of dilevalol and its conjugates in man. Assay method for plasma, blood, urine and bile samples and preliminary pharmacokinetic studiesM Neubeck, C Becker, D Henke, et al.
European Journal of Pharmacology|December 1, 1987
Antimuscarinic action of methoctramine, a new cardioselective M-2 muscarinic receptor antagonist, alone and in combination with atropine and gallamineC Melchiorre, P Angeli, G Lambrecht, et al.
Pageof 37